Advertisement

Topics

AVAIL GmbH Company Profile

15:15 EDT 20th September 2018 | BioPortfolio

AVAIL is the bridge to get your message across easily and effectively when you need to attract attention to your projects and persuade your peers. Our team of specialists in medical writing and scientific communication is committed to serving customers' ends with competence and dedication. We are used to dealing with difficult tasks and can rapidly and reliably help you to deliver your message with impact, regardless of the complexity of your projects. Professionalism, proactivity and capability of working confidently under pressure contribute to the high quality and efficiency of our services.
The benefits of using AVAIL will be to produce successful documents and papers that people read and remember, improve your image, and sell your ideas and products while saving your time and internal resources.

Location

Spalentorweg 18
Basel
CH-4051
Switzerland

Contact

Phone: 41 61 262 3563
Fax: 41 61 262 3562
Email: info@avail.ch


News Articles [165 Associated News Articles listed on BioPortfolio]

Systec GmbH Introduces its new Business Partner Evidencia GmbH

Research, pharmaceuticals, life sciences and food: many laboratories rely on steam sterilizers or equipment where processes are monitored using pressure and temperature control. Thanks to our collabor...

Royalties under patent licence agreements: can they remain payable even if the licensed patents(s) are revoked or not practised? Lessons from Genentech Inc v Hoechst GmbH & Sanofi-Aventis Deutschland GmbH

Précis In its recent decision in Genentech Inc v Hoechst GmbH & Sanofi-Aventis Deutschland GmbH (7 July 2016), the Court of Justice of the EU (“CJEU”) has ruled that an obligati...

Laufende Fusionskontrollverfahren: Bruker Daltonik GmbH, Bremen (D); Erwerb einer Mehrheitsbeteiligung von 80% an der HAIN LIFESCIENCE GmbH, Nehren (D);

Datum der Anmeldung:28.08.2018Aktenzeichen:B3-128/18Unternehmen:Bruker Daltonik GmbH, Bremen (D); Erwerb einer Mehrheitsbeteiligung von 80% an der HAIN LIFESCIENCE GmbH, Nehren (D);Produktmärkte:in.....

Laufende Fusionskontrollverfahren: The Paragon Fund II GmbH & Co. KG, München (D); mittelbarer Erwerb von mindestens 99% der Anteile sowie der Kontrolle über die UCB Innere Medizin GmbH & Co. KG, Monheim (D) und die UCB Primary Care GmbH, Monheim (D);

Datum der Anmeldung:07.08.2018Aktenzeichen:B3-119/18Unternehmen:The Paragon Fund II GmbH & Co. KG, München (D); mittelbarer Erwerb von mindestens 99% der Anteile sowie der Kontrolle über die UCB In....

6 Biggest Mistakes Job Seekers Make

Being active on the job market can be somewhat of an overwhelming undertaking. As the old cliche goes, “it’s a full time job looking for a full time job.” While it’s ok to cut yourself some sl...

Original-Research: CO.DON AG (von Sphene Capital GmbH): Buy

Original-Research: CO.DON AG - von Sphene Capital GmbH Einstufung von Sphene Capital GmbH zu CO.DON AG Unternehmen: CO.DON AG ISIN: DE000A1K0227 Anlass der Studie: Update Report Empfehlung: Buy se...

JA Solar dodáva poločlánkové moduly pre solárne elektrárne v Afrike

Spolutvorcami projektu v Namíbii sú renomovaný nemecký developer SunEQ GmbH, sesterská spoločnosť konzultačnej firmy pre obnoviteľné zdroje energie Suntrace GmbH a popredný nový dodáva...

PH-FIX Indikatorstäbchen pH 4,5-10 100 St MACHEREY-NAGEL GMBH & CO. KG

EUR 10,24Angebotsende: Samstag Apr-7-2018 11:22:08 CESTSofort-Kaufen für nur: EUR 10,24Sofort-Kaufen | Zur Liste der beobachteten Artikel hinzufügen Biotech365 : PH-FIX Indikatorstäbchen pH 4,...

PubMed Articles [18 Associated PubMed Articles listed on BioPortfolio]

Correction to: Lonoctocog Alfa: A Review in Haemophilia A.

The article Lonoctocog Alfa: A Review in Haemophilia A, written by Zaina T. Al-Salama and Lesley J. Scott, was originally published Online First without open access. After publication in volume 77...

Ocular Impression-Taking-Which Material Is Best?

To assess the efficacy and effect on clinical signs of a polyvinylsiloxane (Tresident; Shütz Dental Group GmbH, Germany) compared with an irreversible hydrocolloid (Orthoprint; Zhermack SpA, Badia Po...

Subconjunctival minimally invasive glaucoma surgery : Methods and clinical results.

Minimally invasive glaucoma surgery (MIGS) has been developed for all drainage pathways in glaucoma treatment. Besides implants overriding the resistance in the trabecular meshwork (iStent®, iStent I...

Feminine identity and functional benefits are key factors in women's decision making about upper limb prostheses: a case series.

Although the DEKA Arm promises new abilities, it is unclear if women with upper limb amputation are willing to avail themselves of this new technology. The study purpose was to understand key factors ...

A purpose-designed monofilament-fibre pad for debridement of hard-to-reach wounds: experience in clinical practice.

Effective and comfortable debridement is an important part of managing complex wounds. This user test evaluated a monofilament-fibre pad (with handle) (Debrisoft Lolly, Lohmann & Rauscher GmbH & Co. K...

Clinical Trials [50 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study Comparing Two Test Products With One Reference Product, All Containing 5 mg Yohimbine

- Type: Bioequivalence study in male healthy volunteers, therapeutical indication (erectile disfunction) not studied - Products, dosage, and route of administration: ...

XC8 in the Treatment of Patients With Bronchial Asthma

A multicenter, double-blind, randomized, parallel-group comparative Phase II clinical study to assess the efficacy and safety of different doses of XC8 vs Placebo in patients with partly c...

Bioequivalence Study of Linagliptin From Prevaglip 5 mg Tablets(Eva Pharma, Egypt) and Trajenta 5 mg Tablets (Boehringer Ingelheim International GmbH, Germany)

An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Linagliptin from Prevaglip 5 mg tablets(Eva pharma for Pharmaceuticals & Me...

Avelumab in Relapsed and Refractory Peripheral T-cell Lymphoma

The AVAIL-T trial is a trial to find out how effective avelumab is at treating patients with primary T-cell lymphoma that is refratory to or has relapsed following initial treatment.

A Nutritional Intervention to Decrease Breast Density Among Female BRCA (BReast CAncer Susceptibility Gene) Carriers

The purpose of this study is to determine whether adding DIM supplement will decrease breast density among female BRCA mutation carriers in two years.

Companies [533 Associated Companies listed on BioPortfolio]

AVAIL GmbH

AVAIL is the bridge to get your message across easily and effectively when you need to attract attention to your projects and persuade your peers. Our team of specialists in medical writing and scient...

Chemie-Kontor GmbH

Chemie-Kontor GmbH trades with chemical specialities for customers in Pharma-, Agro-, Cosmetics and Nutrition Industries and offers a broad range of services. Chemie-Kontor GmbH is agent for: Amberger...

OctreoPharm Sciences GmbH

OctreoPharm Sciences GmbH, located in Berlin (Germany) is a privately held clinical development company focusing on radiopharmaceuticals for the diagnosis and therapeutic control ...

Praher Beteiligungs GmbH

The vision of the company founder Ludwig Praher to produce better and better products of high-grade plastics was the basis for sound growth. Under the direction of Ing. Winfried Praher and Ewald Prahe...

Ormecon GmbH

Ormecon GmbH, with its location in Ammersbek/Germany, is the headquarter of Ormecon International. Ormecon GmbH was originally founded as "Ormecon Chemie GmbH & Co. KG" in 1996, as a 100% subsidiary o...

More Information about "AVAIL GmbH" on BioPortfolio

We have published hundreds of AVAIL GmbH news stories on BioPortfolio along with dozens of AVAIL GmbH Clinical Trials and PubMed Articles about AVAIL GmbH for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of AVAIL GmbH Companies in our database. You can also find out about relevant AVAIL GmbH Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Alzheimer's Disease
Of all the types of Dementia, Alzheimer's disease is the most common, affecting around 465,000 people in the UK. Neurons in the brain die, becuase  'plaques' and 'tangles' (mis-folded proteins) form in the brain. People with Al...


Corporate Database Quicklinks



Searches Linking to this Company Record